The National Institutes of Health is offering the Research to Advance Vaccine Safety grant to support exploratory projects focusing on vaccine safety research. This opportunity seeks studies on various aspects of vaccine safety, including physiological responses, genetic influences, risk factors, and molecular technologies. The grant operates under the R21 mechanism and aims to enhance the understanding of vaccine safety. Funding will vary based on project needs and quality of proposals. The closing date for applications is January 07, 2012.
Opportunity ID: 44155
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-08-257 |
| Funding Opportunity Title: | Research to Advance Vaccine Safety (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Environment Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.061 — Innovations in Applied Public Health Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Dec 05, 2008 |
| Last Updated Date: | Jul 28, 2011 |
| Original Closing Date for Applications: | Sep 07, 2011 |
| Current Closing Date for Applications: | Jan 07, 2012 |
| Archive Date: | Feb 07, 2012 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | City or township governments Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments County governments Special district governments Public and State controlled institutions of higher education Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | -Purpose. This FOA, entitled Research to Advance Vaccine Safety, is issued by the National Institutes of Health and encourages Exploratory/Developmental (R21) grant applications from institutions/organizations that propose to support research that will contribute to the overall understanding of vaccine safety.�This R21 research opportunity invites studies that address scientific areas potentially relevant to vaccine safety such as 1) physiological and immunological responses to vaccines and vaccine components, 2) how genetic variations affect immune/physiological responses that may impact vaccine safety, 3) identification of risk factors and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines, or 4) the application of genomic/molecular technologies to improve knowledge of vaccine safety. -Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-08-256 that encourages applications under the NIH research project R01 grant mechanism.-Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the, numbers, quality, duration, and costs of the applications received. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-08-257.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Modified Archive Date based on new Expiration Date, per NOT-AI-11-050. | Jul 28, 2011 | |
| Jul 28, 2011 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-08-257 |
| Funding Opportunity Title: | Research to Advance Vaccine Safety (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Environment Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.061 — Innovations in Applied Public Health Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Dec 05, 2008 |
| Last Updated Date: | Jul 28, 2011 |
| Original Closing Date for Applications: | Sep 07, 2011 |
| Current Closing Date for Applications: | Jan 07, 2012 |
| Archive Date: | Feb 07, 2012 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | City or township governments Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments County governments Special district governments Public and State controlled institutions of higher education Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | -Purpose. This FOA, entitled Research to Advance Vaccine Safety, is issued by the National Institutes of Health and encourages Exploratory/Developmental (R21) grant applications from institutions/organizations that propose to support research that will contribute to the overall understanding of vaccine safety.�This R21 research opportunity invites studies that address scientific areas potentially relevant to vaccine safety such as 1) physiological and immunological responses to vaccines and vaccine components, 2) how genetic variations affect immune/physiological responses that may impact vaccine safety, 3) identification of risk factors and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines, or 4) the application of genomic/molecular technologies to improve knowledge of vaccine safety. -Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-08-256 that encourages applications under the NIH research project R01 grant mechanism.-Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the, numbers, quality, duration, and costs of the applications received. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-08-257.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-08-257 |
| Funding Opportunity Title: | Research to Advance Vaccine Safety (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Environment Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.061 — Innovations in Applied Public Health Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 28, 2011 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Sep 07, 2011 |
| Archive Date: | Oct 08, 2011 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments For profit organizations other than small businesses Special district governments Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Private institutions of higher education Public and State controlled institutions of higher education Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | -Purpose. This FOA, entitled Research to Advance Vaccine Safety, is issued by the National Institutes of Health and encourages Exploratory/Developmental (R21) grant applications from institutions/organizations that propose to support research that will contribute to the overall understanding of vaccine safety. This R21 research opportunity invites studies that address scientific areas potentially relevant to vaccine safety such as 1) physiological and immunological responses to vaccines and vaccine components, 2) how genetic variations affect immune/physiological responses that may impact vaccine safety, 3) identification of risk factors and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines, or 4) the application of genomic/molecular technologies to improve knowledge of vaccine safety. -Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-08-256 that encourages applications under the NIH research project R01 grant mechanism. -Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the, numbers, quality, duration, and costs of the applications received. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-08-257.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| ADOBE-FORMS-A | Adobe-Forms-A | PKG00009503 | Dec 05, 2008 | Feb 20, 2010 | View | |
| ADOBE-FORMS-B1 | Supersedes ADOBE-FORMS-B | PKG00022196 | Oct 29, 2010 | Jan 07, 2012 | View | |
| ADOBE-FORMS-B | Use for submissions intended for due dates of January 25, 2010 and beyond | PKG00015505 | Dec 21, 2009 | Oct 29, 2010 | View |
Package 1
Mandatory forms
44155 RR_SF424-1.1.pdf
44155 RR_KeyPersonExpanded-1.1.pdf
44155 RR_OtherProjectInfo-1.1.pdf
44155 RR_PerformanceSite-1.1.pdf
44155 PHS398_CoverPageSupplement-1.1.pdf
44155 PHS398_ResearchPlan-1.1.pdf
44155 PHS398_Checklist-1.1.pdf
Optional forms
44155 PHS398_CoverLetter-1.1.pdf
44155 PHS398_ModularBudget-1.1.pdf
44155 RR_Budget-1.1.pdf
44155 RR_SubawardBudget-1.2.pdf
Package 2
Mandatory forms
44155 RR_SF424_1_2-1.2.pdf
44155 RR_OtherProjectInfo_1_3-1.3.pdf
44155 RR_KeyPersonExpanded_1_2-1.2.pdf
44155 PerformanceSite_1_4-1.4.pdf
44155 PHS398_ResearchPlan_1_3-1.3.pdf
44155 PHS398_CoverPageSupplement_1_4-1.4.pdf
44155 PHS398_Checklist_1_3-1.3.pdf
Optional forms
44155 RR_Budget-1.1.pdf
44155 RR_SubawardBudget-1.2.pdf
44155 PHS_CoverLetter_1_2-1.2.pdf
44155 PHS398_ModularBudget-1.1.pdf
Package 3
Mandatory forms
44155 RR_SF424_1_2-1.2.pdf
44155 PerformanceSite_1_3-1.3.pdf
44155 RR_OtherProjectInfo_1_2-1.2.pdf
44155 RR_KeyPersonExpanded_1_2-1.2.pdf
44155 PHS398_CoverPageSupplement_1_4-1.4.pdf
44155 PHS398_ResearchPlan_1_3-1.3.pdf
44155 PHS398_Checklist_1_3-1.3.pdf
Optional forms
44155 PHS_CoverLetter_1_2-1.2.pdf
44155 PHS398_ModularBudget-1.1.pdf
44155 RR_Budget-1.1.pdf
44155 RR_SubawardBudget-1.2.pdf
Leave a Reply